User talk:AztecWarrior28

Welcome, and thanks for your articles!
Welcome!

Hello, Tyranitar Man, and welcome to Wikipedia! Thank you for your contributions. I hope you like the place and decide to stay. Here are some pages that you might find helpful: I hope you enjoy editing here and being a Wikipedian! Please sign your messages on discussion pages using four tildes ( ~ ); this will automatically insert your username and the date. If you need help, check out Questions, ask me on my talk page, or ask your question on this page and then place  before the question. Again, welcome! --ἀνυπόδητος (talk) 18:19, 13 September 2011 (UTC)
 * The five pillars of Wikipedia
 * Tutorial
 * How to edit a page and How to develop articles
 * How to create your first article (using the Article Wizard if you wish)
 * Manual of Style
 * Thanks. --Tyranitar Man (talk) 03:24, 15 September 2011 (UTC)

Monoclonal antibodies
Hi, and thank you for the creation of all those monoclonal antibody pages! Could you have another look at the indications/descriptions you mention? For example, atinumab seems to act in the nervous system rather than on the immune system, and vesencumab looks like it would act similarly to a VEGF inhibitor. I think I have come across one or two similar cases, but I can't find them now. Thanks again, ἀνυπόδητος (talk) 18:19, 13 September 2011 (UTC)
 * And thanks for that I appreciate. --Tyranitar Man (talk) 03:25, 15 September 2011 (UTC)

Thanks...
...for the page protection at Rango (2011 film). The IP-jumper linking to the young woman's private Facebook page is seriously creepy. Take a look at how he vandalized my warning to him about it, here. Wow. Amazing. Thank you so much for being proactive. With regards, --Tenebrae (talk) 18:58, 28 November 2011 (UTC)
 * Yes, I know, I really appreciate that. --Tyranitar Man (talk) 18:59, 28 November 2011 (UTC)

voiced labiodental affricate
Hi, you have added  to. Could you create a page for that one, maybe a Redirect? -DePiep (talk) 11:37, 10 December 2011 (UTC)
 * i dunno. I done it already. --Tyranitar Man (talk) 11:38, 10 December 2011 (UTC)

Wikipedia Day Melbourne Meetup
Hi there. Just inviting you to the Melbourne meetup this Sunday at 11am, to celebrate our 11th anniversary. Details on that page. Hope to see you there! SteveBot (talk) 02:17, 11 January 2012 (UTC) (on behalf of Steven Zhang)
 * No thanks. I don't want to. --Tyranitar Man (talk) 02:37, 11 January 2012 (UTC)

February Melbourne Meetup
Hi All. Just letting you know that we have another meetup planned for Melbourne, on Sunday, 26th February at 11am. More details can be found at the meetup page. Pizza will be provided. Look forward to seeing all of you there :-) SteveBot (talk) 23:29, 14 February 2012 (UTC)
 * No thanks, please. --Tyranitar Man (talk) 23:36, 14 February 2012 (UTC)

Melbourne meetup
Hey all, just a reminder that there's a meetup tomorrow at 11am in North Melbourne. There are more details at the meetup page. Hope to see you tomorrow! SteveBot (talk) 05:09, 24 March 2012 (UTC)
 * No thanks. --Tyranitar Man (talk) 03:12, 27 March 2012 (UTC)

Xhosa language
Hi,

Do you have a ref for this edit, for voiceless nasal clicks in Xhosa? (I undid it pending a RS.) I haven't seen them described that way, and so had assumed they were just prenasalized aspirated clicks. It would be interesting if true: I don't think they occur in any other Bantu language. (If you have access to pp 615–616 in Nurse & Philipson The Bantu Languages, that might answer the question.) — kwami (talk) 06:41, 29 May 2012 (UTC)
 * I don't think so. --Tyranitar Man (talk) 08:44, 29 May 2012 (UTC)

Monoclonal antibodies
Hello, and thanks for the info on mAbs. I was wondering if you knew about IMGT/mAb-DB (http://www.imgt.org/mAb-DB/), which is an academic database dedicated to mAbs, and I would like to have your thoughts about it. 195.83.84.65 (talk) 14:19, 11 July 2012 (UTC)
 * Thanks, you're welcome. I might do that soon. --Tyranitar Man (talk) 06:57, 15 July 2012 (UTC)

IPAsym
Please note. When you add an entry to, it should lead to an existing Wikipedia article, not just an IPA symbol name or description. So  should not be a red link. That is the promise of the template, as is described in the documentation. SO the example here could link to existing trill consonant. -DePiep (talk) 10:39, 20 September 2012 (UTC)
 * Yes. --Tyranitar Man (talk) 05:25, 23 September 2012 (UTC)

Meetup invitation: Melbourne 26
Hi there! You are cordially invited to a meetup next Sunday (6 January). Details and an attendee list are at Meetup/Melbourne 26. Hope to see you there! John Vandenberg 07:03, 27 December 2012 (UTC)

(this automated message was delivered using replace.py to all users in Victoria)


 * No thanks. --Tyranitar Man (talk) 11:35, 12 February 2013 (UTC)

ATC codes for raxibacumab and vedolizumab
Hi! I very much appreciate your work on monoclonal antibodies, but can we wait with ATC codes until they are official? These two codes are planned for implementation in 2015(!), and the objection deadline (01.02.2014) hasn't even passed yet. At present, they are unsourced; and in case they won't get implemented, most likely no one will think of removing them from our lists and articles. What do you think? --ἀνυπόδητος (talk) 20:20, 19 December 2013 (UTC)

Reference errors on 5 May
Hello, I'm ReferenceBot. I have automatically detected that an edit performed by you may have introduced errors in referencing. as follows: Please check this page and fix the errors highlighted. If you think this is a false positive, you can [//en.wikipedia.org/w/index.php?action=edit&preload=User:A930913/RBpreload&editintro=User:A930913/RBeditintro&minor=&title=User_talk:A930913&preloadtitle=ReferenceBot%20–%20&section=new report it to my operator]. Thanks, ReferenceBot (talk) 00:24, 6 May 2015 (UTC)
 * On the List of therapeutic monoclonal antibodies page, [//en.wikipedia.org/w/index.php?diff=660923243 your edit] caused a broken reference name (help) . ([ Fix] | [//en.wikipedia.org/w/index.php?title=Wikipedia:Help_desk&action=edit&section=new&preload=User:ReferenceBot/helpform&preloadtitle=Referencing%20errors%20on%20%5B%5BSpecial%3ADiff%2F660923243%7CList of therapeutic monoclonal antibodies%5D%5D Ask for help])

Vietnamese Alphabet/Phonology
Hi, I saw that you've made some adjustments to the diphthong/triphthong section under the Vietnamese Alphabet page. You added 'oeo', 'uyu', 'oao', and 'uơ' to the chart, but I have seen no examples of these glides. Could you provide some examples? Also, the 'qu' combination doesn't really factor into diphthongs or triphthongs, since the 'u' here is actually part of the consonant rather than the vowel. I'm not sure if that may be part of the confusion. Mijcon (talk) 04:34, 29 September 2015 (UTC)
 * uyu: kh uỷu tay (elbow), oeo: ng oèo (winding), oao: ng oáo (bugaboo), uơ: th uở (period-hood) --Tyranitar Man (talk) 11:51, 29 September 2015 (UTC)

ArbCom elections are now open!
Hi, You appear to be eligible to vote in the current Arbitration Committee election. The Arbitration Committee is the panel of editors responsible for conducting the Wikipedia arbitration process. It has the authority to enact binding solutions for disputes between editors, primarily related to serious behavioural issues that the community has been unable to resolve. This includes the ability to impose site bans, topic bans, editing restrictions, and other measures needed to maintain our editing environment. The arbitration policy describes the Committee's roles and responsibilities in greater detail. If you wish to participate, you are welcome to review the candidates' statements and submit your choices on the voting page. For the Election committee, MediaWiki message delivery (talk) 16:52, 24 November 2015 (UTC)

Disambiguation link notification for September 10
Hi. Thank you for your recent edits. Wikipedia appreciates your help. We noticed though that when you edited Bagdasarian, you added a link pointing to the disambiguation page Ross Bagdasarian. Such links are almost always unintended, since a disambiguation page is merely a list of "Did you mean..." article titles. Read the FAQ* Join us at the DPL WikiProject.

It's OK to remove this message. Also, to stop receiving these messages, follow these opt-out instructions. Thanks, DPL bot (talk) 10:54, 10 September 2016 (UTC)

Disambiguation link notification for January 5
Hi. Thank you for your recent edits. An automated process has detected that when you recently edited List of therapeutic monoclonal antibodies, you added links pointing to the disambiguation pages NACP and BAFF ([//dispenser.info.tm/~dispenser/cgi-bin/dablinks.py/List_of_therapeutic_monoclonal_antibodies check to confirm] | [//dispenser.info.tm/~dispenser/cgi-bin/dab_solver.py/List_of_therapeutic_monoclonal_antibodies?client=notify fix with Dab solver]). Such links are usually incorrect, since a disambiguation page is merely a list of unrelated topics with similar titles. (Read the FAQ* Join us at the DPL WikiProject.)

It's OK to remove this message. Also, to stop receiving these messages, follow these opt-out instructions. Thanks, DPL bot (talk) 09:08, 5 January 2018 (UTC)

Nomination of Afasevikumab for deletion
A discussion is taking place as to whether the article Afasevikumab is suitable for inclusion in Wikipedia according to Wikipedia's policies and guidelines or whether it should be deleted.

The article will be discussed at Articles for deletion/Afasevikumab until a consensus is reached, and anyone is welcome to contribute to the discussion. The nomination will explain the policies and guidelines which are of concern. The discussion focuses on high-quality evidence and our policies and guidelines.

Users may edit the article during the discussion, including to improve the article to address concerns raised in the discussion. However, do not remove the article-for-deletion notice from the top of the article. Natureium (talk) 19:56, 8 January 2018 (UTC)

Nomination of Navicixizumab for deletion
A discussion is taking place as to whether the article Navicixizumab is suitable for inclusion in Wikipedia according to Wikipedia's policies and guidelines or whether it should be deleted.

The article will be discussed at Articles for deletion/Navicixizumab until a consensus is reached, and anyone is welcome to contribute to the discussion. The nomination will explain the policies and guidelines which are of concern. The discussion focuses on high-quality evidence and our policies and guidelines.

Users may edit the article during the discussion, including to improve the article to address concerns raised in the discussion. However, do not remove the article-for-deletion notice from the top of the article. Natureium (talk) 20:01, 8 January 2018 (UTC)

Nomination of Cergutuzumab amunaleukin for deletion
A discussion is taking place as to whether the article Cergutuzumab amunaleukin is suitable for inclusion in Wikipedia according to Wikipedia's policies and guidelines or whether it should be deleted.

The article will be discussed at Articles for deletion/Cergutuzumab amunaleukin until a consensus is reached, and anyone is welcome to contribute to the discussion. The nomination will explain the policies and guidelines which are of concern. The discussion focuses on high-quality evidence and our policies and guidelines.

Users may edit the article during the discussion, including to improve the article to address concerns raised in the discussion. However, do not remove the article-for-deletion notice from the top of the article. Natureium (talk) 20:02, 8 January 2018 (UTC)

Nomination of Duvortuxizumab for deletion
A discussion is taking place as to whether the article Duvortuxizumab is suitable for inclusion in Wikipedia according to Wikipedia's policies and guidelines or whether it should be deleted.

The article will be discussed at Articles for deletion/Duvortuxizumab until a consensus is reached, and anyone is welcome to contribute to the discussion. The nomination will explain the policies and guidelines which are of concern. The discussion focuses on high-quality evidence and our policies and guidelines.

Users may edit the article during the discussion, including to improve the article to address concerns raised in the discussion. However, do not remove the article-for-deletion notice from the top of the article. Natureium (talk) 20:08, 8 January 2018 (UTC)

Nomination of Gancotamab for deletion
A discussion is taking place as to whether the article Gancotamab is suitable for inclusion in Wikipedia according to Wikipedia's policies and guidelines or whether it should be deleted.

The article will be discussed at Articles for deletion/Gancotamab until a consensus is reached, and anyone, including you, is welcome to contribute to the discussion. The nomination will explain the policies and guidelines which are of concern. The discussion focuses on high-quality evidence and our policies and guidelines.

Users may edit the article during the discussion, including to improve the article to address concerns raised in the discussion. However, do not remove the article-for-deletion notice from the top of the article.  DGG ( talk ) 06:35, 24 September 2018 (UTC)

Nomination of Frovocimab for deletion
A discussion is taking place as to whether the article Frovocimab is suitable for inclusion in Wikipedia according to Wikipedia's policies and guidelines or whether it should be deleted.

The article will be discussed at Articles for deletion/Frovocimab until a consensus is reached, and anyone, including you, is welcome to contribute to the discussion. The nomination will explain the policies and guidelines which are of concern. The discussion focuses on high-quality evidence and our policies and guidelines.

Users may edit the article during the discussion, including to improve the article to address concerns raised in the discussion. However, do not remove the article-for-deletion notice from the top of the article.  DGG ( talk ) 06:43, 24 September 2018 (UTC)

Nomination of Birtamimab for deletion
A discussion is taking place as to whether the article Birtamimab is suitable for inclusion in Wikipedia according to Wikipedia's policies and guidelines or whether it should be deleted.

The article will be discussed at Articles for deletion/Birtamimab until a consensus is reached, and anyone, including you, is welcome to contribute to the discussion. The nomination will explain the policies and guidelines which are of concern. The discussion focuses on high-quality evidence and our policies and guidelines.

Users may edit the article during the discussion, including to improve the article to address concerns raised in the discussion. However, do not remove the article-for-deletion notice from the top of the article.  DGG ( talk ) 06:44, 24 September 2018 (UTC)

Nomination of Gosuranemab for deletion
A discussion is taking place as to whether the article Gosuranemab is suitable for inclusion in Wikipedia according to Wikipedia's policies and guidelines or whether it should be deleted.

The article will be discussed at Articles for deletion/Gosuranemab until a consensus is reached, and anyone, including you, is welcome to contribute to the discussion. The nomination will explain the policies and guidelines which are of concern. The discussion focuses on high-quality evidence and our policies and guidelines.

Users may edit the article during the discussion, including to improve the article to address concerns raised in the discussion. However, do not remove the article-for-deletion notice from the top of the article.  DGG ( talk ) 06:47, 24 September 2018 (UTC)

Disambiguation link notification for September 25
An automated process has detected that when you recently edited Relatlimab, you added a link pointing to the disambiguation page Phase II ([//dispenser.info.tm/~dispenser/cgi-bin/dablinks.py/Relatlimab check to confirm] | [//dispenser.info.tm/~dispenser/cgi-bin/dab_solver.py/Relatlimab?client=notify fix with Dab solver]).

(Opt-out instructions.) --DPL bot (talk) 09:18, 25 September 2018 (UTC)

Proposed deletion of Dostarlimab
Hello, Tyranitar Man. I wanted to let you know that I’m proposing an article that you started, Dostarlimab, for deletion because I don't think it meets our criteria for inclusion. If you don't want the article deleted:


 * 1) [//en.wikipedia.org/w/index.php?title=&action=edit edit the page]
 * 2) remove the text that looks like this:
 * 3) save the page

Also, be sure to explain why you think the article should be kept in your edit summary or on the article's talk page. If you don't do so, it may be deleted later anyway.

You can leave a note on my talk page if you have questions.

Natureium (talk) 23:36, 25 September 2018 (UTC)

Nomination of Marstacimab for deletion
A discussion is taking place as to whether the article Marstacimab is suitable for inclusion in Wikipedia according to Wikipedia's policies and guidelines or whether it should be deleted.

The article will be discussed at Articles for deletion/Marstacimab until a consensus is reached, and anyone, including you, is welcome to contribute to the discussion. The nomination will explain the policies and guidelines which are of concern. The discussion focuses on high-quality evidence and our policies and guidelines.

Users may edit the article during the discussion, including to improve the article to address concerns raised in the discussion. However, do not remove the article-for-deletion notice from the top of the article.  DGG ( talk ) 08:56, 29 September 2018 (UTC)

Proposed deletion of Tamtuvetmab


The article Tamtuvetmab has been proposed for deletion&#32;because of the following concern: "too early for an article: no information available about its potential use as a drug.I cannot find anythingin in PubMed,"

While all constructive contributions to Wikipedia are appreciated, pages may be deleted for any of several reasons.

You may prevent the proposed deletion by removing the notice, but please explain why in your edit summary or on the article's talk page.

Please consider improving the page to address the issues raised. Removing will stop the proposed deletion process, but other deletion processes exist. In particular, the speedy deletion process can result in deletion without discussion, and articles for deletion allows discussion to reach consensus for deletion.  DGG ( talk ) 08:20, 16 October 2018 (UTC)

Proposed deletion of Blontuvetmab


The article Blontuvetmab has been proposed for deletion&#32;because of the following concern: "too early for an article: no information available about its potential use as a drug.I cannot find anythingin in PubMed,"

While all constructive contributions to Wikipedia are appreciated, pages may be deleted for any of several reasons.

You may prevent the proposed deletion by removing the notice, but please explain why in your edit summary or on the article's talk page.

Please consider improving the page to address the issues raised. Removing will stop the proposed deletion process, but other deletion processes exist. In particular, the speedy deletion process can result in deletion without discussion, and articles for deletion allows discussion to reach consensus for deletion.  DGG ( talk ) 08:20, 16 October 2018 (UTC)

Nomination of Bemarituzumab for deletion
A discussion is taking place as to whether the article Bemarituzumab is suitable for inclusion in Wikipedia according to Wikipedia's policies and guidelines or whether it should be deleted.

The article will be discussed at Articles for deletion/Bemarituzumab until a consensus is reached, and anyone, including you, is welcome to contribute to the discussion. The nomination will explain the policies and guidelines which are of concern. The discussion focuses on high-quality evidence and our policies and guidelines.

Users may edit the article during the discussion, including to improve the article to address concerns raised in the discussion. However, do not remove the article-for-deletion notice from the top of the article. Hitro talk 07:37, 9 November 2018 (UTC)

"Over (word)" listed at Redirects for discussion
An editor has asked for a discussion to address the redirect Over (word). Since you had some involvement with the Over (word) redirect, you might want to participate in the redirect discussion if you wish to do so. Shhhnotsoloud (talk) 13:04, 2 February 2020 (UTC)

"Vamos (Spanish word)" listed at Redirects for discussion
An editor has asked for a discussion to address the redirect Vamos (Spanish word). Since you had some involvement with the Vamos (Spanish word) redirect, you might want to participate in the redirect discussion if you wish to do so. Shhhnotsoloud (talk) 14:39, 2 February 2020 (UTC)

Nomination for deletion of Template:Base 36
Template:Base 36 has been nominated for deletion. You are invited to comment on the discussion at the entry on the Templates for discussion page. User:GKFXtalk 18:52, 3 October 2021 (UTC)

ArbCom 2022 Elections voter message
 Hello! Voting in the 2022 Arbitration Committee elections is now open until 23:59 (UTC) on. All eligible users are allowed to vote. Users with alternate accounts may only vote once.

The Arbitration Committee is the panel of editors responsible for conducting the Wikipedia arbitration process. It has the authority to impose binding solutions to disputes between editors, primarily for serious conduct disputes the community has been unable to resolve. This includes the authority to impose site bans, topic bans, editing restrictions, and other measures needed to maintain our editing environment. The arbitration policy describes the Committee's roles and responsibilities in greater detail.

If you wish to participate in the 2022 election, please review the candidates and submit your choices on the voting page. If you no longer wish to receive these messages, you may add to your user talk page. MediaWiki message delivery (talk) 01:07, 29 November 2022 (UTC)

Your signature and linter errors
Just a reminder that your signature contains obsolete font tags. They create Linter errors, and it is advised that you change your signature to  ASAP.

The purpose of this message is because Linter errors affect the way the page looks, and with a lot of errors, the page may render badly. To reduce Linter errors, please change your signature. See WP:SIGFONT for more info.

If the software doesn't accept my replacement signature, let me know, and I may give you another replacement signature to use. Otherwise, you may have to change it to something else. Sheep (talk • he/him) 16:59, 14 February 2023 (UTC)

Done.  Aztec Warrior &#124;  talk  &#124;  contribs  18:54, 14 February 2023 (UTC)

ArbCom 2023 Elections voter message
 Hello! Voting in the 2023 Arbitration Committee elections is now open until 23:59 (UTC) on. All eligible users are allowed to vote. Users with alternate accounts may only vote once.

The Arbitration Committee is the panel of editors responsible for conducting the Wikipedia arbitration process. It has the authority to impose binding solutions to disputes between editors, primarily for serious conduct disputes the community has been unable to resolve. This includes the authority to impose site bans, topic bans, editing restrictions, and other measures needed to maintain our editing environment. The arbitration policy describes the Committee's roles and responsibilities in greater detail.

If you wish to participate in the 2023 election, please review the candidates and submit your choices on the voting page. If you no longer wish to receive these messages, you may add to your user talk page. MediaWiki message delivery (talk) 00:40, 28 November 2023 (UTC)

"CAT:OAXACA" listed at Redirects for discussion
The redirect [//en.wikipedia.org/w/index.php?title=CAT:OAXACA&redirect=no CAT:OAXACA] has been listed at redirects for discussion to determine whether its use and function meets the redirect guidelines. Anyone, including you, is welcome to comment on this redirect at  until a consensus is reached. Utopes (talk / cont) 03:58, 13 December 2023 (UTC)